OTC Markets EXMKT - Delayed Quote USD
Transgene SA (TRGNF)
2.0000
+1.3000
+(185.71%)
At close: June 5 at 8:00:00 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | -- | -- | 6.7M | 6.7M |
| Low Estimate | -- | -- | 6.7M | 6.7M |
| High Estimate | -- | -- | 6.7M | 6.7M |
| Year Ago Sales | -- | -- | 6.35M | 6.7M |
| Sales Growth (year/est) | -- | -- | 5.46% | 0.00% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| TRGNF | -- | -- | -- | -- |
| S&P 500 | 13.13% | 2.46% | 7.55% | 14.08% |
Related Tickers
ALINT.PA IntegraGen SA
0.5200
-0.38%
ALTHX.PA Theranexus Société Anonyme
0.9200
-2.13%
2X1.SG Abivax SA
7.18
+3.46%
PHXM.PA PHAXIAM Therapeutics S.A.
0.2210
+9.95%
ALSEN.PA Sensorion SA
0.4100
0.00%
OSE.PA OSE Immunotherapeutics SA
5.52
-6.28%
BRNS Barinthus Biotherapeutics plc
0.9903
+0.03%
NANO.PA Nanobiotix S.A.
4.1000
-1.32%
LPTX Leap Therapeutics, Inc.
0.4106
+4.48%
RNA Avidity Biosciences, Inc.
32.66
-9.88%